美国的移植系统.

Same author

Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.

Transplantation proceedings·2002

Same author

Late mortality after orthotopic liver transplantation.

American journal of surgery·2001

Same author

Successful treatment of aggressive post transplant lymphoproliferative disorder using rituximab.

Leukemia & lymphoma·2001

Same author

Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation.

Transplantation proceedings·2001

Same author

Prophylactic antiviral therapy in CMV high-risk liver transplant recipients.

Transplantation proceedings·2001

Same author

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2001

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

美国的移植系统.

相关概念视频

Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.

Late mortality after orthotopic liver transplantation.

Successful treatment of aggressive post transplant lymphoproliferative disorder using rituximab.

Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation.

Prophylactic antiviral therapy in CMV high-risk liver transplant recipients.

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

美国的移植系统.

相关概念视频

相关文章

Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.

Late mortality after orthotopic liver transplantation.

Successful treatment of aggressive post transplant lymphoproliferative disorder using rituximab.

Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation.

Prophylactic antiviral therapy in CMV high-risk liver transplant recipients.

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.